News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,389 Results
Type
Article (62452)
Company Profile (169)
Press Release (627768)
Section
Business (186770)
Career Advice (2818)
Deals (34679)
Drug Delivery (102)
Drug Development (79619)
Employer Resources (163)
FDA (16208)
Job Trends (15287)
News (326964)
Policy (32914)
Tag
Academia (2855)
Alliances (47316)
Alzheimer's disease (1236)
Approvals (16131)
Artificial intelligence (141)
Bankruptcy (317)
Best Places to Work (11950)
Biotechnology (101)
Breast cancer (124)
Cancer (1088)
Cardiovascular disease (96)
Career advice (2386)
Cell therapy (247)
Clinical research (63150)
Collaboration (392)
Compensation (117)
COVID-19 (2694)
C-suite (105)
Data (1122)
Diabetes (151)
Diagnostics (6433)
Drug pricing (95)
Earnings (64990)
Employer resources (144)
Events (109841)
Executive appointments (325)
FDA (16762)
Funding (350)
Gene therapy (177)
GLP-1 (588)
Government (4902)
Healthcare (19904)
Infectious disease (2781)
Inflammatory bowel disease (114)
Interviews (539)
IPO (15689)
Job creations (3711)
Job search strategy (2013)
Layoffs (456)
Legal (7486)
Lung cancer (171)
Manufacturing (181)
Medical device (13580)
Medtech (13585)
Mergers & acquisitions (19087)
Metabolic disorders (408)
Neuroscience (1511)
NextGen Class of 2024 (7047)
Non-profit (4928)
Northern California (1413)
Obesity (236)
Opinion (225)
Patents (103)
People (59715)
Phase I (19832)
Phase II (27700)
Phase III (20524)
Pipeline (444)
Postmarket research (2637)
Preclinical (8311)
Radiopharmaceuticals (250)
Rare diseases (223)
Real estate (6230)
Regulatory (21865)
Research institute (2546)
Resumes & cover letters (420)
Southern California (1237)
Startups (3580)
United States (13070)
Vaccines (608)
Weight loss (176)
Date
Today (138)
Last 7 days (862)
Last 30 days (3786)
Last 365 days (35157)
2024 (32191)
2023 (39439)
2022 (50493)
2021 (55588)
2020 (54810)
2019 (48888)
2018 (37168)
2017 (32862)
2016 (32802)
2015 (38432)
2014 (31427)
2013 (27422)
2012 (28989)
2011 (29248)
2010 (27658)
Location
Africa (974)
Arizona (163)
Asia (40528)
Australia (7223)
California (3138)
Canada (1256)
China (248)
Colorado (146)
Connecticut (156)
Europe (92348)
Florida (441)
Georgia (124)
Illinois (376)
Indiana (203)
Kansas (95)
Maryland (565)
Massachusetts (2450)
Michigan (166)
Minnesota (259)
New Jersey (930)
New York (928)
North Carolina (743)
Northern California (1413)
Ohio (141)
Pennsylvania (791)
South America (1291)
Southern California (1237)
Texas (440)
Washington State (361)
690,389 Results for "national institute of health nih".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxxas Licenses Next-Generation Vaccine for Respiratory Syncytial Virus (RSV) from the United States National Institutes of Health (NIH)
October 28, 2024
·
6 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Pharm Country
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute
Xylyx Bio, Inc. announced that it has been awarded a Small Business Innovation Research Fast-Track grant from the National Cancer Institute of the National Institutes of Health to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for metastatic breast cancer.
June 14, 2024
·
2 min read
Biotech Beach
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study
Daré Bioscience, Inc. today announced that it received a Notice of Award of a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a division of the National Institutes of Health (NIH).
December 13, 2023
·
10 min read
Drug Development
Daxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services Program
Daxor Corporation today announces it has been accepted into the National Institutes of Health (NIH) Catalyze Preclinical Services Program.
October 4, 2023
·
4 min read
Business
The Foundation for the National Institutes of Health Appoints Love Collins, III to Lead Advancement and Development
The Foundation for the National Institutes of Health announces that Love Collins, III, has joined as Vice President of Advancement.
May 13, 2024
·
3 min read
Press Releases
Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
November 6, 2024
·
4 min read
Business
The Foundation for the National Institutes of Health Appoints James W. Down and Perry Steiner to Its Board of Directors
The Foundation for the National Institutes of Health announces two additions to the FNIH Board of Directors: James W. Down, former Vice Chairman of Mercer Management Consulting, and Perry Steiner, Chairman and CEO of Xactus.
May 29, 2024
·
3 min read
Biotech Bay
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.
June 10, 2024
·
5 min read
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
SeaStar Medical Holding Corporation announces that the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute has awarded a $3.6 million grant for a clinical trial to evaluate the Selective Cytopheretic Device Adult (SCD-ADULT.
April 30, 2024
·
8 min read
1 of 69,039
Next
